Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Characteristics of study participants. Variables | All (n = 231) | Subjects without NAFLD (n = 102, 44.2%) | Subjects with NAFLD (n = 129, 55.8%) | P value: 25-hydroxy vitamin D (IU) | 22.7 ± 10.9 | 22.6 ± 10.4 | 23.0 ± 11.2 | 0.830

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This is a cross-sectional analysis of 231 asymptomatic subjects (160 women, 61.6 years old) from a university hospital setting, between February 2012 and December 2014.

Source: Abstract.

As shown in , exclusion criteria for this study were as follows: women aged ≤50 years (n = 57) to exclude pre-menopausal women, any etiological markers for chronic liver disease including positive serologic markers for hepatitis B virus (n = 53) and hepatitis C virus (n = 17), autoimmune hepatitis (n = 5), history of alcohol consumption >210 g/week for men and 140 g/week for women (n = 7), presence of primary biliary cirrhosis (n = 3), presence of right-sided heart failure (n = 4), prior history of malignancy (n = 9), invalid liver stiffness value (n = 12), and sequential data from identical subjects (n = 42).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease

Cross-sectional study · PLoS ONE · 2017

Original publication title

Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease

Gyuri Kim; Kwang Joon Kim; Yumie Rhee; Sung-Kil Lim

© 2017 Kim et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The presence of significant liver fibrosis assessed via TE was independently associated with low BMD in NAFLD subjects.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Metabolic bone disorders frequently occur in patients with chronic liver disease; however, the association between liver fibrosis and bone mineral density in patients with non-alcoholic fatty liver disease (NAFLD) is unclear.

Source: Background

Abstract: What methods does the paper describe?

This is a cross-sectional analysis of 231 asymptomatic subjects (160 women, 61.6 years old) from a university hospital setting, between February 2012 and December 2014. Bone mineral density (BMD) was measured at the lumbar spine, femur neck, and total hip using dual-energy X-ray absorptiometry (DXA). Liver fibrosis and steatosis were assessed using transient elastography.

Source: Methods

Abstract: Results

Among a total of 231 individuals, 129 subjects (55.8%) had NAFLD. BMDs at lumbar spine, femur neck, and total hip were significantly lower in patients having NAFLD with significant fibrosis, compared with patients having NAFLD without significant fibrosis (Ps<0.005). In patients with NAFLD, significant liver fibrosis revealed marked negative correlations with BMD at the lumber spine (r =: 0.19, P = 0.032), femur neck (r =: 0.19, P = 0.034), and total hip (r =: 0.21, P = 0.016).

A multivariate linear regression analysis revealed that significant liver fibrosis was independently correlated with low BMD at the femur neck (β =: 0.18, P = 0.039) and total hip (β =: 0.21, P = 0.005) after adjustment for age, sex, BMI, fasting plasma glucose, alanine aminotransferase, high-density lipoprotein cholesterol, and liver steatosis among patients with NAFLD. Using multivariable logistic regression, significant liver fibrosis was independently associated with overall osteopenia and osteoporosis in subjects having NAFLD (OR = 4.10, 95% CI = 1.02 to 16.45).

Source: Results

Abstract: Conclusion

The presence of significant liver fibrosis assessed via TE was independently associated with low BMD in NAFLD subjects.

Source: Conclusion
Authors’ abstract

Background

Metabolic bone disorders frequently occur in patients with chronic liver disease; however, the association between liver fibrosis and bone mineral density in patients with non-alcoholic fatty liver disease (NAFLD) is unclear.

Methods

This is a cross-sectional analysis of 231 asymptomatic subjects (160 women, 61.6 years old) from a university hospital setting, between February 2012 and December 2014. Bone mineral density (BMD) was measured at the lumbar spine, femur neck, and total hip using dual-energy X-ray absorptiometry (DXA). Liver fibrosis and steatosis were assessed using transient elastography.

Results

Among a total of 231 individuals, 129 subjects (55.8%) had NAFLD. BMDs at lumbar spine, femur neck, and total hip were significantly lower in patients having NAFLD with significant fibrosis, compared with patients having NAFLD without significant fibrosis (Ps<0.005). In patients with NAFLD, significant liver fibrosis revealed marked negative correlations with BMD at the lumber spine (r =: 0.19, P = 0.032), femur neck (r =: 0.19, P = 0.034), and total hip (r =: 0.21, P = 0.016).

A multivariate linear regression analysis revealed that significant liver fibrosis was independently correlated with low BMD at the femur neck (β =: 0.18, P = 0.039) and total hip (β =: 0.21, P = 0.005) after adjustment for age, sex, BMI, fasting plasma glucose, alanine aminotransferase, high-density lipoprotein cholesterol, and liver steatosis among patients with NAFLD. Using multivariable logistic regression, significant liver fibrosis was independently associated with overall osteopenia and osteoporosis in subjects having NAFLD (OR = 4.10, 95% CI = 1.02 to 16.45).

Conclusion

The presence of significant liver fibrosis assessed via TE was independently associated with low BMD in NAFLD subjects.

Publication and source details

Original title: Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease

Gyuri Kim; Kwang Joon Kim; Yumie Rhee; Sung-Kil Lim

PLoS ONE · 2017

Competing Interests: The authors have declared that no competing interests exist.

  • Conceptualization: GK SKL.

  • Data curation: GK KJK.

  • Formal analysis: GK.

  • Funding acquisition: SKL.

  • Investigation: GK KJK YR SKL.

  • Methodology: GK SKL.

  • Project administration: GK KJK YR SKL.

  • Resources: GK KJK YR SKL.

  • Software: GK.

  • Supervision: KJK YR SKL.

  • Validation: GK KJK YR SKL.

  • Visualization: GK.

  • Writing: original draft: GK.

  • Writing: review & editing: GK KJK YR SKL.

* E-mail: LSK@yuhs.ac
© 2017 Kim et al2017Kim et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.The author(s) received no specific funding for this work.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T19:33:59.197994+00:00

DOI: 10.1371/journal.pone.0182202 · PMC5536288